WallStreetZenWallStreetZen

NASDAQ: AKTX
Akari Therapeutics PLC Stock Ownership - Who owns Akari Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Akari Therapeutics PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kameel D. FaragInterim CFO2025-11-0132,000$0.75
$24.00kBuy
Kameel D. FaragInterim CFO2025-11-0126,619$0.75
$19.96kBuy
Kameel D. FaragInterim CFO2025-10-226,277$0.74
$4.64kBuy
Abizer GaslightwalaCEO2025-08-253,000$0.90
$2.70kBuy
Abizer GaslightwalaCEO2025-08-228,000$0.93
$7.44kBuy
Abizer GaslightwalaCEO2025-08-2110,000$0.94
$9.40kBuy
Abizer GaslightwalaPresident CEO2025-06-245,203$1.16
$6.04kBuy

1 of 1

AKTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AKTX insiders and whales buy or sell their stock.

AKTX Shareholders

What type of owners hold Akari Therapeutics PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Rachelle Suzanne Jacques1.11%1,018,027,792$11.14BInsider
Stuart Ungar0.79%722,345,600$7.90BInsider
Ray Prudo0.79%722,345,600$7.90BInsider
Rpc Pharma Ltd0.79%722,345,600$7.90BInsider
James Hill0.79%722,345,600$7.90BInsider
Hoyoung Huh0.24%223,719,311$2.45BInsider
Wendy F. Dicicco0.17%158,473,915$1.73BInsider
Sandip I. Patel0.13%121,026,008$1.32BInsider
Donald A. Williams0.02%20,000,000$218.80MInsider
Michael Grissinger0.02%20,000,000$218.80MInsider

1 of 3

AKTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AKTX0.00%4.87%Net Buying
NCNA0.00%0.01%
SCNI0.00%7.26%
BDRX0.00%0.00%
ADTX0.41%99.59%Net SellingNet Selling
View Top Biotech Stocks

Akari Therapeutics Stock Ownership FAQ

Who owns Akari Therapeutics?

Akari Therapeutics (NASDAQ: AKTX) is owned by 0.00% institutional shareholders, 4.87% Akari Therapeutics insiders, and 95.13% retail investors. Rachelle Suzanne Jacques is the largest individual Akari Therapeutics shareholder, owning 1.02B shares representing 1.11% of the company. Rachelle Suzanne Jacques's Akari Therapeutics shares are currently valued at $11.43B.

If you're new to stock investing, here's how to buy Akari Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.